Oncode Accelerator

Oncode Accelerator

Research Services

Outsmarting cancer. Impacting lives.

About us

Oncode Accelerator is a public-private partnership that is funded by the Dutch National Growth Fund (NGF), which aims to innovate, optimize, and accelerate the development of new cancer therapies to address the unmet medical need. It is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.

Industry
Research Services
Company size
11-50 employees
Type
Nonprofit
Founded
2023
Specialties
Oncology, Research, Cancer therapies, preclinical therapeutic development, and cancer research

Employees at Oncode Accelerator

Updates

Similar pages